The European Commission has shortlisted 11 new projects worth 120 million euros ($140 million) from Horizon Europe, the biggest European research and innovation programme (2021-2027), for supporting and enabling urgent research into the coronavirus and its variants.
This funding is part of a wide range of research and innovation actions carried out to fight the coronavirus. It will contribute to the Commission's overall action to prevent, mitigate and respond to the impact of the virus and its variants, in line with the new European bio-defence preparedness plan HERA Incubator.
The 11 shortlisted projects include 312 research teams from 40 countries, among these 38 participants from 23 countries outside of the EU.
9 of these projects will be managed by HaDEA, 3 from the topic "Cohorts united against COVID-19 variants of concern" and 6 from the topic "Clinical trials for therapeutics and vaccines".
Image source in article: Fusion Medical Animation on Unsplash
- Datum der Veröffentlichung
- 26. Juli 2021
- Programme Sector
- Horizon EuropeHorizon Europe Cluster 1: Health
- Medical researchScientific research